Clinical trials are the final stages of cancer research that assess a potential new drug or therapy that’s already been studied extensively in the laboratory. Trials are carefully monitored scientific studies that involve patients and offer the earliest access to these newest treatment options.
Trials are conducted to determine a drug’s proper dose, how well it works and whether it’s more effective than current standard treatments. All drugs and treatment approaches currently used as standard of care were once studied in clinical trials.
Why it matters
Participating in a clinical trial is the only way to access the very latest options, oftentimes years before they become available to other providers. If you have lymphoma, you need the very best treatment today, not years from now.
Through clinical trials, Roswell Park patients were among the first to benefit from these game-changing treatments:
- Polatuzumab vedotin (Polivy), a treatment for many patients with diffuse large B-cell lymphoma (DLBCL) who cannot be treated with other available drugs.
- Rituximab (Rituxan), the first monoclonal antibody approved to treat patients with B-cell lymphoma.
- Lenalidomide (Revlimid), an immunomodulatory drug for the treatment of diffuse large B-cell lymphoma, follicular lymphoma and mantle cell lymphoma
- Cladribine (Mavenclad), used for the treatment of non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), acute myeloid leukemia and other conditions.